reduc
immunogen
therebi
efficaci
unfortun
downsid
vaccin
base
highli
purifi
synthet
antigen
requir
use
vaccin
adjuv
improv
vaccin
immunogen
term
adjuv
tradit
refer
substanc
ad
vaccin
antigen
increas
immunogen
studi
adjuv
action
made
complic
wide
divers
agent
includ
small
molecul
immun
modul
miner
salt
oil
emuls
even
whole
virus
bacteria
agent
exhibit
adjuv
action
vivo
one
common
featur
explain
activ
almost
certainli
compound
work
mani
vari
differ
mechan
enhanc
immun
respons
coadminist
antigen
increas
use
small
protein
peptid
antigen
allow
greater
control
vaccin
design
synthesi
exacerb
issu
poor
immunogen
necessit
closer
examin
best
design
vaccin
deliveri
adjuv
system
maxim
antigen
immunogen
assist
target
immun
deliveri
provid
potent
adjuv
activ
importantli
must
done
manner
compromis
vaccin
toler
safeti
immun
system
evolv
protect
invad
pathogen
pathogen
present
nanoto
micros
particl
surpris
immun
system
evolv
strategi
specif
recogn
respond
particl
particular
size
shape
help
explain
boost
immunogen
antigen
present
immun
system
viruslik
particl
vlp
rather
solubl
protein
particl
size
shown
import
uptak
dendrit
cell
dc
spheric
particl
less
nm
diamet
better
uptak
larger
particl
size
also
relev
cell
matur
wherebi
poli
lactidecoglycolid
plga
microparticl
modifi
recognit
costimulatori
ligand
similar
dimens
dc
better
abl
induc
cell
activ
compar
nanos
particl
rapidli
phagocytos
idea
size
import
vaccin
action
well
accept
also
like
shape
textur
surfac
chemistri
equal
highli
relev
adjuv
action
albeit
less
wellexplor
shape
known
import
particl
uptak
vivo
halflif
biodistribut
exampl
cylindr
silicon
particl
exhibit
strong
liver
accumul
wherea
discoid
particl
accumul
away
liver
spheric
particl
distribut
evenli
across
tissu
decreas
diamet
spheric
particl
result
increas
accumul
reticuloendotheli
tissu
tissu
rich
variou
immun
cell
consequ
accumul
reticuloendotheli
system
advantag
vaccin
standpoint
notabl
highaxialratio
nanoparticl
shown
better
target
drain
lymph
node
therebi
enhanc
antigen
present
memori
b
cell
respons
surfac
chemistri
also
shown
import
adjuv
particl
properti
uptak
larger
particl
dc
enhanc
posit
surfac
charg
furthermor
nm
diamet
polyhydroxyl
polymethoxyl
poli
propylen
sulfid
nanoparticl
polystyren
nanoparticl
equal
effici
induc
dc
uptak
polyhydroxyl
particl
induc
high
level
dc
matur
effect
attribut
polyhydroxyl
surfac
activ
complement
therebi
act
immun
danger
signal
dc
activ
use
hydrophil
polymer
coat
polyethylen
glycol
polyzwitterion
overal
neutral
surfac
charg
bind
water
surfac
also
shown
chang
particl
behavior
hydrophob
region
amphiphil
system
consid
act
immun
danger
signal
provid
adjuv
effect
mechan
properti
yet
anoth
factor
need
taken
account
assess
immun
effect
particl
macrophag
dc
shown
preferenti
phagocytos
rigid
particl
even
ident
surfac
chemistri
softer
particl
henc
make
particl
flexibl
mimic
red
blood
cell
properti
shown
increas
halflif
vivo
wherea
make
rigid
improv
uptak
dc
therebi
immun
action
increasingli
sophist
particl
manufactur
approach
enabl
evertight
control
size
shape
extern
chemistri
mechan
properti
adjuv
particl
provid
uniqu
opportun
modifi
vaccin
adjuv
particl
aim
maxim
biolog
action
remaind
chapter
describ
wide
varieti
nanoand
microparticul
vaccin
adjuv
system
method
manufactur
size
shape
surfac
chemistri
import
adjuv
action
fig
emuls
compos
dispers
droplet
one
liquid
anoth
immisc
liquid
commonli
describ
either
waterinoil
oilinwat
emuls
use
adjuv
droplet
emuls
act
particl
perceiv
immun
system
two
differ
form
nanoscal
emuls
defin
droplet
radii
nm
suffici
small
gener
transpar
isotrop
liquid
media
first
form
nanoscal
emuls
histor
term
microemuls
better
describ
nanodimension
lyotrop
liquid
crystallin
phase
microemuls
structur
organ
two
liquid
support
rel
larg
concentr
surfact
format
spontan
selfassembl
rel
gentl
mix
result
stabl
organ
thermodynam
equilibrium
contrast
term
nanoemuls
gener
use
significantli
less
surfact
henc
requir
high
shear
forc
make
metast
structur
emuls
adjuv
thought
work
depot
effect
creat
inflamm
around
site
antigen
inject
therebi
enhanc
humor
immun
respons
earli
exampl
emuls
adjuv
waterinmineraloil
emuls
howev
adjuv
problemat
miner
oil
biodegrad
proinflammatori
longterm
persist
bodi
therebi
lead
major
inflammatori
side
effect
includ
inject
site
granuloma
pyrexia
longterm
safeti
issu
care
must
also
taken
emuls
adjuv
avoid
oxid
oil
compon
could
otherwis
lead
increas
vaccin
reactogen
gener
oilinwat
nanoemuls
use
biodegrad
oil
better
toler
profil
waterinoil
formul
wellknown
exampl
oilinwat
nanoemuls
adjuv
compos
squalen
oil
citrat
buffer
use
nonion
surfact
nanoemuls
key
adjuv
effect
test
individu
variou
compon
fail
demonstr
adjuv
activ
vaccin
formul
use
extens
research
recent
work
includ
test
cation
nanoemuls
deliveri
system
deliveri
selfamplifi
mrna
vaccin
nonetheless
bulk
research
influenza
vaccin
licens
purpos
elderli
human
extens
safeti
data
elderli
popul
limit
safeti
data
avail
use
children
potenti
relev
pandem
influenza
vaccin
contain
squalenebas
nanoemuls
similar
except
addit
tocopherol
associ
rise
childhood
case
narcolepsi
autoimmun
sleep
disord
put
question
pediatr
safeti
squalenebas
emuls
adjuv
back
spotlight
immunogen
emuls
adjuv
increas
coformul
addit
immunestimulatori
compon
interestingli
origin
squalen
emuls
adjuv
initi
design
deliveri
system
muramyl
tripeptid
phosphatidylethanolamin
mtppe
modifi
mycobacteri
peptidoglycan
potent
adjuv
activ
mtppe
activ
innat
immun
receptor
includ
nucleotidebind
oligomer
domaincontain
protein
variou
tolllik
receptor
tlr
lead
nuclear
factor
kappab
activ
induct
inflammatori
cytokin
howev
mtppe
compon
ultim
remov
excess
reactogen
recent
version
combin
adjuv
emuls
immunostimul
approach
adjuv
oilinwat
emuls
combin
saponin
agonist
monophosphoryl
lipid
mpl
intranas
deliveri
vaccin
provid
advantag
term
conveni
induct
mucos
immun
major
benefit
protect
respiratori
mucos
pathogen
nasal
vaccin
contain
soybean
oil
nanoemuls
adjuv
success
enhanc
humor
cellular
respons
mice
consist
util
approach
librari
intranas
adjuv
candid
formul
consist
oilinwat
nanoemuls
contain
variou
cation
nonion
surfact
test
mice
demonstr
vari
physicochem
properti
surfact
compon
charg
surfact
polar
head
size
hydrophob
surfact
blend
ratio
intranas
adjuv
formul
could
modul
strength
type
immun
respons
indic
may
consider
scope
optim
nanoemuls
adjuv
intranas
use
howev
toler
safeti
human
approach
yet
confirm
recent
shown
nanoemuls
adjuv
induc
epitheli
cell
death
via
activ
caspas
furthermor
safeti
nasal
vaccin
adjuv
remain
cloud
sinc
experi
nasalflu
intranas
influenza
vaccin
contain
detoxifi
enterotoxin
adjuv
associ
increas
case
facial
nerv
palsi
clinic
trial
multipl
doubl
emuls
often
waterinoilinwat
formul
also
use
vaccin
research
howev
waterinoilinwat
multipl
emuls
prove
less
stabl
induc
excess
inflammatori
respons
compar
oilinwat
microemuls
isopropyl
myrist
success
enhanc
humor
respons
rabi
vaccin
mice
stabil
issu
aris
two
interfac
high
free
energi
stabil
gener
requir
two
surfact
may
interact
therebi
interf
stabil
also
multipl
emuls
potenti
osmot
pressur
develop
place
strain
system
even
simpl
emuls
without
issu
nanoemuls
thermodynam
equilibrium
poor
stabil
microemuls
suffer
need
high
concentr
surfact
may
caus
toxic
vivo
furthermor
stabil
microemuls
easili
compromis
dilut
heat
ph
chang
variou
nanoparticl
construct
disord
precipit
polym
also
describ
nanobead
use
vaccin
deliveri
nanoparticl
two
size
made
mean
diamet
nm
solvent
evapor
smaller
diamet
particl
found
adjuv
effect
elicit
cellular
humor
respons
mice
polystyren
nanobead
coval
conjug
ovalbumin
found
best
activ
cell
nm
diamet
bead
rang
size
nm
diamet
compar
anoth
studi
found
larger
bead
diamet
nm
best
activ
cell
thu
may
possibl
specif
tune
nanoparticl
size
induc
either
cellular
humor
immun
anoth
system
poli
acid
graft
lphenylalanin
ethyl
ester
carboxyl
acid
group
selfassembl
upon
addit
water
organ
solut
nanoparticl
diamet
nm
presenc
ovalbumin
nanoparticl
encapsul
antigen
target
dc
result
enhanc
dc
matur
immun
inorgan
nanoparticl
use
vaccin
deliveri
vehicl
aluminum
oxid
nanoparticl
distinctli
better
perform
compar
metal
oxid
nanoparticl
aluminum
oxid
nanoparticl
nm
diamet
elicit
adjuv
effect
peptom
deriv
hiv
antigen
sequenc
retain
nativ
conform
coval
attach
extern
surfac
aluminum
oxid
nanoparticl
also
function
ovalbumin
shown
enhanc
dc
activ
cell
via
autophagydepend
mechan
particl
size
also
shown
import
nm
nanoparticl
effect
vitro
nm
aluminum
oxid
particl
much
effect
transport
drain
lymph
node
vivo
vlp
made
use
recombin
protein
techniqu
wherebi
antigen
protein
hbsag
synthes
yeast
follow
antigen
selfassembl
nm
vlp
vlp
safe
immunogen
make
ideal
vaccin
antigen
howev
cellcultur
system
use
manufactur
vlp
low
yield
expens
henc
synthet
method
develop
vlp
product
exampl
short
linear
synthet
protein
coiledcoil
domain
use
selfassembl
motifcontain
nanoparticl
abl
present
repetit
epitop
surfac
synthet
particl
nm
diamet
elicit
strong
immun
respons
surfaceexpress
epitop
relat
nanoparticul
vaccin
deliveri
system
also
assembl
peptid
chain
contain
coiledcoil
sequenc
drive
helic
assembl
instanc
peptid
modifi
nterminu
dual
chain
lipid
synthet
epitop
cterminu
upon
dispers
aqueou
solut
construct
aggreg
order
synthet
particl
diamet
nm
present
multipl
copi
antigen
surfac
induc
humor
immun
respons
anoth
synthet
system
polypeptid
design
selfassembl
nanofib
epitop
attach
cterminu
gener
strong
antibodi
respons
without
inflamm
similarli
vlp
selfassembl
structur
critic
adjuv
affect
unassembl
sequenc
adjuv
properti
shown
nanofib
intern
dc
macrophag
inject
site
result
increas
express
activ
marker
enhanc
product
follicular
helper
cell
germin
center
b
cell
nanostructur
materi
within
tissu
depot
may
also
gener
adjuv
activ
peptid
altern
hydrophob
hydrophil
amino
acid
undergo
solgel
transit
upon
exposur
physiolog
condit
wherebi
form
hydrogel
made
interconnect
nanofib
way
mixtur
biphas
oligopeptid
antigen
adjuv
inject
peptid
subsequ
undergo
postinject
selfassembl
hydrat
nanofib
gel
matric
form
antigen
adjuv
depot
aqueou
phase
selfassembl
nanofibr
hydrogel
induc
antibodi
respons
test
vaccin
deliveri
platform
either
alon
formul
cpg
adjuv
agonist
deliveri
system
recombin
hepat
b
surfac
antigen
hbsag
similarli
selfassembl
peptid
conjug
cell
epitop
ovalbumin
elicit
strong
antigenspecif
tcell
respons
liposomebas
vaccin
earli
form
particul
adjuv
formul
base
use
celllik
spheric
lipid
bilay
vesicl
contain
antigen
within
intern
aqueou
compart
within
lipid
bilay
attach
extern
exampl
nmdiamet
liposom
assembl
cation
lipid
cation
polym
plasmid
dna
shown
target
antigen
drain
lymph
node
result
enhanc
dc
activ
immun
coat
liposom
cholesterolmodifi
mannan
enhanc
therapeut
anticanc
action
oncoprotein
vaccin
liposom
gener
poorli
immunogen
may
requir
combin
immunostimulatori
adjuv
enhanc
immunogen
exampl
liposom
nanoparticl
selfassembl
mixtur
phospholipid
contain
pegyl
lipid
prevent
protein
bind
use
target
cyclic
diguanyl
agonist
stimul
inf
gene
drain
lymph
node
therebi
enhanc
vaccin
potenc
singl
bilay
liposom
also
construct
use
viral
lipid
envelop
retain
viral
cell
bind
fusion
glycoprotein
result
nmdiamet
virosom
promot
attach
respiratori
mucos
surfac
subsequ
fusion
releas
content
cytoplasm
endocytos
cell
viral
compon
enhanc
effici
interact
antigenpres
cell
apc
make
ideal
vaccin
deliveri
system
recent
virosom
research
includ
incorpor
addit
compon
improv
particl
format
stabil
characterist
well
enhanc
immunogen
exampl
amphiphil
saponin
deriv
incorpor
virosom
provid
potent
immunogen
allow
use
low
antigen
dose
electrostat
interact
import
part
nanoparticl
vaccin
formul
compon
formul
formul
anion
cell
membran
apc
charg
interact
demonstr
import
variou
nanovaccin
includ
liposom
system
perhap
best
exploit
polymer
system
mixtur
anion
poli
acid
acid
graft
phenylalanin
ethylest
cation
selfassembl
aqueou
solut
nanoparticl
nm
diamet
form
presenc
ovalbumin
particl
load
antigen
induc
effect
cellular
humor
immun
respons
immun
mice
poli
acid
also
eletrostat
attach
complex
dendrigraft
polyllysin
plasmid
dna
instanc
poli
acid
moder
cytotox
electrostat
complex
enabl
deliveri
express
gene
spleen
suggest
applic
vaccin
formul
relat
similar
gene
deliveri
formul
electrostat
interact
posit
charg
polyethyleneimin
neg
charg
plasmid
dna
poli
acid
use
construct
nanoparticl
dna
vaccin
formul
confer
protect
malaria
infect
mous
model
standard
plga
particl
neg
charg
electrostat
interact
identifi
critic
aspect
bind
protein
antigen
consequ
protein
bind
tune
adjust
ph
bind
condit
optim
charg
differenti
compon
plga
nanoparticl
also
construct
posit
charg
use
print
technolog
incorpor
cation
addit
particl
specif
design
electrostat
interact
commerci
hemagglutinin
antigen
gener
influenza
vaccin
enhanc
immun
respons
compar
hemagglutinin
alon
lipidlik
amphiphil
use
sever
selfassembl
nanoparticulatebas
selfadjuv
antigen
deliveri
system
structur
mimic
bacteri
lipoprotein
activ
immun
system
type
vaccin
formul
includ
hydrophob
core
coval
attach
hydrophil
peptid
antigen
antigen
epitop
present
surfac
nanoparticl
nontox
dendrit
poli
tertbutyl
acryl
polym
core
use
conjug
relev
peptid
epitop
induc
cellular
respons
abl
kill
human
papillomavirusinfect
cancer
cell
epitop
pack
particl
surfac
dens
enough
maintain
nativ
conform
enabl
proper
recognit
immun
system
exampl
particl
core
made
either
lipidlik
peptid
lipid
peptid
formul
includ
peptid
epitop
hookworm
protein
flank
coilproduc
sequenc
attach
lipidlik
peptid
core
nativ
alpha
helix
structur
epitop
present
surfac
nanoparticl
abl
gener
antibodi
mice
previous
suggest
use
emuls
liposom
adjuv
saponin
provid
potent
immunogen
vaccin
formul
commonli
use
adjuv
saponin
acyl
saponin
posit
fucos
two
link
acid
induc
inflammatori
cytokin
impart
bia
vaccin
respons
abil
lyse
cell
membran
hemolysi
inject
site
pain
major
limit
factor
use
toxic
reduc
form
immunestimul
complex
iscom
spheric
particl
nm
diamet
selfassembl
specif
mixtur
cholesterol
phospholipid
advantag
iscom
toxic
hemolyt
effect
saponin
moder
incorpor
liposom
structur
immunestimulatori
properti
retain
liposom
particl
also
help
target
saponin
adjuv
antigen
formul
drain
lymph
node
initi
thought
import
immunogen
antigen
load
insid
iscom
structur
recogn
adjuv
action
achiev
simpl
admixtur
antigen
iscom
major
advantag
mani
antigen
difficult
load
particl
mani
plantbas
polysaccharid
shown
adjuv
activ
addit
benefit
sugarbas
compound
polysaccharid
gener
extrem
safe
well
toler
polysaccharid
eg
mannan
may
adjuv
activ
solubl
form
adjuv
activ
present
insolubl
particl
clearli
seen
polysaccharid
inulin
poli
fructofuranosyl
dglucos
natur
plantderiv
storag
carbohydr
plant
composita
famili
immunolog
activ
usual
solubl
form
potent
adjuv
activ
crystal
nanostructur
delta
inulin
microparticl
delta
inulin
particl
shown
enhanc
humor
cellular
immun
respons
wide
varieti
viral
bacteri
protozoan
antigen
well
toxin
allergen
exampl
enhanc
vaccin
protect
seen
model
influenza
japanes
enceph
west
nile
viru
hepat
b
human
immunodefici
viru
anthrax
sar
coronaviru
listeriosi
african
hors
sick
adjuv
effect
seen
across
broad
rang
anim
speci
includ
mice
rat
guinea
pig
rabbit
chicken
dog
sheep
monkey
hors
camel
prove
effect
human
studi
combin
recombin
pandem
influenza
vaccin
hepat
b
vaccin
bee
sting
allergi
vaccin
interest
featur
delta
inulin
abil
enhanc
adapt
immun
respons
even
inject
day
prior
antigen
featur
share
alum
adjuv
delta
inulin
work
like
polysaccharid
adjuv
found
activ
innat
immun
receptor
tlr
inflammasom
instead
delta
inulin
adjuv
appear
work
directli
modul
dc
function
therebi
result
enhanc
antigen
present
memori
b
cell
recent
shown
human
subject
translat
enhanc
b
cell
receptor
affin
matur
upregul
activationinduc
cytidin
deamidas
day
postimmun
plasmablast
notabl
delta
inulin
prove
safe
effect
administ
pregnant
dam
mous
pup
larg
anim
model
either
pregnant
mare
foal
featur
may
attribut
noninflammatori
mode
action
interestingli
powder
particl
formul
delta
inulin
recent
shown
safe
effect
administ
influenza
vaccin
directli
lung
mice
open
novel
vaccin
applic
technolog
polysaccharid
particl
adjuv
activ
includ
dextran
lentinan
zymosan
mannan
chitosan
work
action
specif
innat
immun
receptor
express
apc
known
lectin
specif
recogn
respond
sugar
includ
receptor
mannan
receptor
dectin
tlr
activ
innat
immun
receptor
result
activ
product
proinflammatori
cytokin
enhanc
adapt
immun
respons
henc
delta
inulin
current
appear
polysaccharid
particul
adjuv
work
altern
noninflammatori
pathway
given
high
express
lectin
apc
decor
surfac
vaccin
adjuv
particl
sugar
group
assist
vaccin
particl
target
apc
exampl
mannos
use
target
plasmid
dnacontain
liposom
macrophag
coat
cation
liposom
mannan
significantli
enhanc
abil
dna
vaccin
induc
hivspecif
cellular
immun
also
enhanc
activ
dna
vaccin
melanoma
mannosyl
niosom
compos
span
cholesterol
stearylamin
coat
modifi
polysaccharid
opalmitoyl
mannan
use
oral
administ
dna
vaccin
carrier
demonstr
enhanc
mucos
immun
mice
similar
approach
use
opalmitoyl
mannan
coat
use
target
niosom
langerhan
cell
skin
topic
deliveri
chitin
linear
polym
dglucosamin
nacetyldglucosamin
extract
shrimp
chitosan
obtain
partial
deacetyl
chitin
act
bind
innat
receptor
includ
macrophag
mannos
receptor
chitosan
particl
produc
crosslink
counter
ion
use
entrap
antigen
enhanc
immunogen
mice
virtu
mucoadhes
qualiti
particl
coat
chitin
deriv
extens
use
nasal
adjuv
deliveri
inactiv
even
live
viral
vector
henc
mucos
deliveri
adenovir
vector
microencapsul
chitosan
microparticl
help
protect
improv
viabil
viral
vector
also
made
releas
depend
cell
surfac
contact
given
abil
specif
nanoparticl
target
apc
discuss
previous
particl
also
load
immun
stimul
increas
adjuv
potenc
mdp
nacetyl
muramyllalaninedisoglutamin
mycobacteri
peptidoglycan
potent
adjuv
activ
bind
activ
tlr
receptor
lead
activ
inflammatori
cytokin
product
dc
matur
modifi
form
mtppe
key
immun
stimul
origin
emuls
adjuv
design
deliveri
system
given
highli
hydrophob
natur
mtppe
iron
combin
mtppe
formul
abandon
excess
reactogen
vehicl
found
adjuv
activ
right
henc
use
influenza
vaccin
continu
similar
fashion
liposom
formul
dtpgdp
nacetylglucosaminylnacetylmuramyllaladisoglulalaglyceroldipalmit
potent
adjuv
activ
induc
remiss
human
metastat
colorect
cancer
although
reactogen
fever
chill
hypotens
problem
higher
dose
combin
chitosan
microparticl
mucos
toxinbas
adjuv
significantli
enhanc
immunogen
intranas
group
c
meningococc
polysaccharid
vaccin
mice
similarli
intranas
administr
alginateco
chitosan
nanoparticl
load
antigen
cpg
adjuv
enhanc
antibodi
cellular
respons
mice
cpg
also
incorpor
hydrophil
head
group
lipidlik
adjuv
macromolecul
hydrophob
tail
compos
cholesterol
simpl
monoacyl
diacyl
lipid
group
formul
use
success
target
cpg
adjuv
antigen
lymph
node
therebi
help
decreas
system
cpg
toxic
enhanc
vaccin
immunogen
emuls
use
adjuv
discuss
earlier
also
use
templat
produc
controlleds
solid
adjuv
particl
fig
use
method
polysaccharid
inulin
cosolubil
ovalbumin
antigen
waterinoil
emuls
inulin
precipit
slow
addit
aceton
result
format
spheric
inulin
particl
encapsul
ovalbumin
high
effici
antigenload
inulin
microparticl
improv
apc
uptak
ovalbumin
enhanc
antiovalbumin
antibodi
respons
mice
emuls
similarli
use
templat
precipit
mani
biodegrad
polymer
nanoparticl
use
vaccin
deliveri
includ
format
plga
nanoparticl
nanoemuls
plga
nanoparticl
act
antigen
deliveri
system
although
unlik
inulin
particl
plga
particl
appear
intrins
adjuv
properti
immunomodul
requir
creat
strong
immun
respons
contrast
poli
acid
base
nanoparticl
gener
immun
respons
without
requir
adjuv
emuls
polymer
anoth
method
wherebi
polymer
particl
size
defin
emuls
gener
method
solubl
polym
droplet
within
emuls
chemic
crosslink
droplets
particl
remain
solid
emuls
remov
poli
ortho
ester
microparticl
diamet
produc
way
use
deliv
plasmid
dna
antigen
apc
acid
condit
apc
lysosom
degrad
orthoest
bond
hold
particl
togeth
therebi
releas
dna
dna
transcrib
protein
present
b
cell
result
cellular
humor
memori
respons
anoth
exampl
sizetun
crosslink
poli
propylen
sulfid
nanoparticl
size
rang
nm
prepar
emuls
monom
water
phase
stabil
pluron
particl
size
control
vari
concentr
monom
surfact
emuls
particl
present
pluron
hydroxyl
group
surfac
result
complement
activ
dc
matur
strong
adjuv
effect
particl
unstabl
releas
attach
drug
oxid
condit
found
lysosom
abil
produc
particl
differ
size
enabl
effect
particl
size
antigen
deliveri
directli
studi
reveal
small
nm
nanoparticl
deliv
attach
antigen
drain
lymph
node
higher
effici
nm
particl
studi
use
particl
shown
particl
surfac
chemistri
import
action
nanoadjuv
exampl
polyhydroxyl
surfac
perform
much
better
polymethoxyl
surfac
despit
particl
target
dc
control
product
defineds
adjuv
nanoparticl
also
achiev
particl
replic
nonwet
templat
print
technolog
print
techniqu
use
photolithographi
creat
templat
transfer
perfluoropolyeth
elastom
mold
mold
fill
desir
materi
pressur
allow
set
releas
materi
mold
produc
particl
nanoor
microscal
complex
highli
conserv
morpholog
technolog
use
rang
medic
applic
includ
product
stimulirespons
target
drug
deliveri
vehicl
vaccin
adjuv
size
shape
chemistri
print
nanoparticl
optim
maxim
transport
lymph
node
enabl
use
antigen
deliveri
vehicl
work
found
anion
x
nm
cylind
coval
bound
ovalbumin
polyethylen
glycol
spacer
optim
deliveri
antigen
lymph
node
enhanc
vaccin
respons
chapter
highlight
increas
sophist
vaccin
adjuv
design
driven
converg
improv
immunolog
understand
import
nanofeatur
adjuv
function
togeth
advanc
nanomanufactur
techniqu
allow
precis
control
particl
size
shape
textur
surfac
chemistri
principl
antigen
design
eg
particl
selfassembl
increasingli
incorpor
adjuv
nanoparticl
design
individu
concept
appli
design
singl
integr
vaccin
particl
incorpor
antigen
adjuv
apctarget
strategi
process
concept
adjuv
need
broaden
includ
specif
immunestimulatori
substanc
also
includ
vaccin
design
featur
enhanc
immun
respons
relev
antigen
thu
definit
adjuv
could
potenti
includ
aspect
antigen
formul
nanoparticl
incorpor
aspect
particl
size
shape
surfac
chemistri
enhanc
immunogen
even
pure
physic
process
textur
particl
surfac
maxim
immunogen
look
forward
adjuv
increasingli
seen
separ
addon
item
wholli
integr
element
complet
vaccin
deliveri
packag
vaccin
system
steadili
approach
complex
sophist
pathogen
mimic
particl
properti
behavior
design
maxim
longterm
immun
protect
maintain
high
safeti
profil
